Microbiology
-
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
This article has 19 authors:Reviewed by ScreenIT
-
Coronavirus activates a stem cell-mediated defense mechanism that reactivates dormant tuberculosis: implications in COVID-19 pandemic
This article has 9 authors:Reviewed by ScreenIT
-
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
This article has 14 authors:Reviewed by ScreenIT
-
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
This article has 25 authors:Reviewed by ScreenIT
-
Multiple SARS-CoV-2 Introductions Shaped the Early Outbreak in Central Eastern Europe: Comparing Hungarian Data to a Worldwide Sequence Data-Matrix
This article has 22 authors:Reviewed by ScreenIT
-
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2
This article has 12 authors:Reviewed by ScreenIT
-
Selectomic and Evolvability Analyses of the Highly Pathogenic Betacoronaviruses SARS-CoV-2, SARS-CoV, and MERS-CoV
This article has 3 authors:Reviewed by ScreenIT
-
Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids
This article has 29 authors:Reviewed by ScreenIT
-
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light
This article has 5 authors:Reviewed by ScreenIT
-
PSGL-1 inhibits the virion incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins and impairs virus attachment and infectivity
This article has 8 authors:Reviewed by ScreenIT